查找临床试验

已按「系统性硬化症」检索,对应国际通用词 systemic sclerosis

试验不在中国怎么办?

共找到 155 项正在招募的试验

数据更新于 00:23,每 5 分钟自动同步
正在招募I 期中国有中心NCT06978647

A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases

China

年龄 18 Years – 65 Years

China Immunotech (Beijing) Biotechnology Co., Ltd.

正在招募II 期中国有中心NCT06794008

BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases

China

年龄 18 Years – 65 Years

Peking University People's Hospital

正在招募不适用NCT01793168

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

United States

年龄 不限 – 不限

Sanford Health

正在招募I 期中国有中心NCT06980597

A Study of OL-108 in Relapsed/Refractory Autoimmune Diseases

China

年龄 18 Years – 65 Years

Beijing GoBroad Hospital

正在招募I 期中国有中心NCT06941129

CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases

China

年龄 18 Years – 不限

Institute of Hematology & Blood Diseases Hospital, China

正在招募不适用NCT07650565

Tissue Modeling in Systemic Sclerosis Using Induced Pluripotent Stem Cells (iPSCs)

France

年龄 18 Years – 85 Years

University Hospital, Montpellier

正在招募I 期NCT07284797

A Phase 1 Open-label Study to Evaluate Safety in Healthy Participants and Participants With Autoimmune Diseases

Australia

年龄 18 Years – 75 Years

Xencor, Inc.

正在招募II 期NCT07047690

A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis

United States、Switzerland

年龄 18 Years – 不限

Galderma R&D

正在招募不适用NCT05365009

Registry of Autoimmune Interstitial Lung Disease

Argentina

年龄 18 Years – 不限

EPIMAR registry

正在招募II 期NCT06195072

Platform Clinical Study for Conquering Scleroderma

United States

年龄 18 Years – 不限

Scleroderma Research Foundation, Inc.

正在招募不适用NCT06256575

Study of Diosmin for the Treatment of Digital Ulcers in Systemic Sclerosis

Canada

年龄 18 Years – 不限

Primus Pharmaceuticals

正在招募早期 I 期中国有中心NCT06888960

Safety Study of CC312 in Autoimmune Disease Patients

China

年龄 18 Years – 不限

CytoCares Inc